3 unknown, 2 completed, 1 recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Unknown 3, Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow CHU de Reims: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection Arikayce, standard treatment - Mycobacterium; Xenopi, Lung Diseases | Phase 2 | Recruiting | Centre Hospitalier Universitaire, Amiens | 190 | 2024-10-20 | 2026-10-27 |
| Efficacy and Safety of Ustekinumab in Bullous Pemphigoid Ustekinumab - Bullous Pemphigoid | Phase 2 | Completed | CHU de Reims | 18 | 2020-03-11 | 2023-08-08 |
| Cell Therapy in Critical Limb Ischemia allogeneic umbilical cord-derived mesenchymal stem cells, Placebo (NaCl) - Critical Limb Ischemia | Phase 2 | Unknown | CHU de Reims | 30 | 2019-09-01 | 2019-06-21 |
| Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas carboplatine, Etoposide, radiation therapy - Medulloblastoma | Phase 2 | Unknown | Central Hospital, Nancy, France | 97 | 2013-04-10 | 2018-07-05 |
| EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety Eplerenone - Chronic Kidney Insufficiency, Kidney Transplantation | Phase 2 | Unknown | CHU de Reims | 31 | 2013-02-01 | 2013-04-18 |
| Cell Therapy in Chronic Limb Ischemia BM-MNC preparation, PB-MNC preparation - Peripheral Vascular Diseases | Phase 1 / Phase 2 | Completed | CHU de Reims | 40 | 2004-10-01 | 2009-02-06 |
Chronic Limb-Threatening Ischemia (1) · Lung Diseases (1) · Medulloblastoma (1) · Mycobacterium Infections (1) · Pemphigoid, Bullous (1) · Peripheral Vascular Diseases (1) · Renal Insufficiency, Chronic (1)
Carboplatin (1) · Eplerenone (1) · Etoposide (1) · Radiotherapy (1) · Ustekinumab (1)
France (6)